Alimera Sciences (ALIM) Misses Q3 EPS by 5c

Alimera Sciences (NASDAQ: ALIM) reported Q3 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $10.53 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Ideal Power (IPWR) Tops Q2 EPS by 2c
• Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c